Implantable Cardiac Monitors Sales

Implantable Cardiac Monitors Sales Market Outlook

The global market for Implantable Cardiac Monitors is projected to reach USD 5.1 billion by 2035, with a compound annual growth rate (CAGR) of 6.8% during the forecast period of 2025 to 2035. This growth can be attributed to the rising prevalence of cardiovascular diseases globally, which necessitates the need for advanced monitoring solutions. Furthermore, the increasing adoption of technologically advanced devices in the healthcare sector, coupled with the growing geriatric population, is expected to propel market growth. Additionally, innovations in implantable cardiac devices, such as wireless connectivity and enhanced battery life, are likely to open new avenues for market expansion. The increasing focus on personalized medicine and home healthcare solutions also presents significant opportunities for the growth of the implantable cardiac monitors market.

Growth Factor of the Market

The implantable cardiac monitors market is benefiting from several growth factors, the most significant of which is the rising incidence of arrhythmias and other heart-related disorders worldwide. As healthcare providers shift towards early diagnosis and preventive measures, the demand for continuous cardiac monitoring is increasing. Technological advancements, such as the development of miniaturized devices with improved functionality, are attracting both patients and healthcare providers, thereby boosting market growth. Moreover, the increase in healthcare expenditure, particularly in emerging economies, is enhancing access to advanced cardiac monitoring systems, further driving market demand. The integration of wireless technologies in implantable devices facilitates real-time monitoring and data transmission, enhancing patient outcomes and fueling market expansion. Additionally, supportive government initiatives aimed at improving cardiovascular care are expected to contribute positively to the growth of this market.

Key Highlights of the Market

• The global implantable cardiac monitors market is projected to reach USD 5.1 billion by 2035.
• The market is anticipated to grow at a CAGR of 6.8% between 2025 and 2035.
• Technological advancements are driving innovations in implantable cardiac monitoring devices.
• Rising prevalence of cardiovascular diseases is a key driver of market growth.
• Supportive government initiatives are enhancing access to cardiac monitoring technologies globally.

By Product Type

Insertable Loop Recorders:

Insertable loop recorders (ILRs) are devices designed to monitor heart rhythms over an extended period, making them particularly effective for detecting intermittent arrhythmias. These devices are implanted just below the skin and can record the heart's electrical activity continuously for up to three years. The demand for ILRs is growing, primarily due to their ability to provide long-term monitoring without the need for frequent replacements. Their small size and minimally invasive nature make them a preferred choice among patients. Moreover, advancements in ILR technology, such as improved data storage and wireless transmission capabilities, are enhancing their utility in clinical settings, thereby driving market growth within this segment.

Implantable Cardioverter Defibrillators:

Implantable cardioverter defibrillators (ICDs) are critical devices used to monitor and treat life-threatening arrhythmias. They are designed to deliver electric shocks to restore normal heart rhythm when needed. The increasing prevalence of sudden cardiac arrest and other heart conditions requiring immediate intervention is propelling the demand for ICDs. Furthermore, the integration of advanced algorithms and remote monitoring capabilities in modern ICDs ensures better patient management and outcomes. The growing awareness regarding sudden cardiac death and the benefits of early intervention are also contributing to the expansion of this market segment.

Subcutaneous Implantable Cardioverter Defibrillators:

Subcutaneous implantable cardioverter defibrillators (S-ICDs) represent an emerging option in cardiac monitoring and intervention, characterized by their positioning entirely beneath the skin without transvenous leads. This design reduces the risks associated with traditional ICDs, such as infection and lead failure. The growing preference for S-ICDs can be attributed to their efficacy, safety profile, and lower complication rates. Additionally, the rise in patient awareness regarding the advantages of S-ICDs over traditional systems is fueling market growth in this category. As manufacturers continue to innovate and improve these devices, adoption is expected to increase significantly.

Cardiac Resynchronization Therapy Devices:

Cardiac resynchronization therapy (CRT) devices are designed to improve the heart's efficiency and function in patients with heart failure. These devices synchronize the contractions of the heart chambers, thereby enhancing cardiac output and overall quality of life for patients. The growing prevalence of heart failure, coupled with advancements in CRT technology, is driving the demand for these devices. Moreover, increased awareness and diagnosis of heart failure are leading to a more significant number of patients being referred for CRT, which is further propelling market growth in this segment.

Others:

This category includes various other implantable cardiac devices that support patient monitoring and treatment. These devices may range from specialized pacemakers to newer innovative technologies that cater to specific cardiac conditions. The market for 'Others' is growing due to the continued innovation and development of niche products aimed at addressing specific patient needs. As healthcare providers increasingly recognize the importance of tailored treatment options, the demand for specialized implantable cardiac devices is expected to rise, thereby contributing to the overall market growth.

By Application

Arrhythmias:

The application of implantable cardiac monitors in treating arrhythmias is significant, given the rising incidence of these conditions globally. Arrhythmias refer to abnormal heart rhythms that can lead to serious health complications, including stroke and heart failure. The ability of implantable cardiac monitors to provide continuous and accurate data on heart rhythms enables timely interventions. The increasing awareness among physicians and patients about the importance of monitoring arrhythmias for effective treatment is driving the growth of this application segment. Moreover, advancements in diagnostic technology are making it easier for healthcare providers to detect and manage arrhythmias, contributing to this segment's expansion.

Atrial Fibrillation:

Atrial fibrillation (AF) is one of the most common types of arrhythmia, characterized by rapid and irregular heartbeat. The growing prevalence of AF, driven by an aging population and rising risk factors such as obesity and hypertension, is significantly boosting the demand for implantable cardiac monitors. These devices allow for real-time monitoring of heart activity, facilitating early intervention and management of AF. Recent clinical studies have underscored the effectiveness of continuous monitoring in reducing complications associated with AF, which further propels the adoption of implantable devices in this application area. The ongoing research in AF management and device innovations ensures sustained growth in this sector.

Heart Failure:

Heart failure is a chronic condition that has serious implications for patient health and quality of life. Implantable cardiac monitors play a crucial role in the management of heart failure by providing continuous monitoring of cardiac function and enabling timely medical interventions. As the population ages and the prevalence of heart failure rises, the demand for advanced monitoring solutions is increasing. The ability of these devices to track changes in heart function and notify healthcare providers of potential complications is enhancing patient management. Furthermore, the growing understanding of the link between early monitoring and improved outcomes in heart failure patients is driving the growth of this application segment.

Others:

The 'Others' application segment encompasses a variety of medical conditions for which implantable cardiac monitors can be used. This includes the monitoring of patients with congenital heart diseases, post-operative monitoring, and other specific cardiac issues. As the technology behind implantable devices continues to evolve, their applications are expanding, leading to increased utilization in non-traditional settings. The versatility of these devices in catering to diverse patient needs is expected to foster growth within this segment as healthcare providers seek innovative solutions for comprehensive cardiac care.

By Distribution Channel

Hospitals:

Hospitals are a primary distribution channel for implantable cardiac monitors, accounting for a significant share of the market. They are equipped with the necessary infrastructure and skilled healthcare professionals to perform the implantation procedures safely and effectively. Furthermore, hospitals often have direct access to patients with severe heart conditions who require continuous monitoring. The increasing number of hospitals adopting advanced cardiac care technologies and expanding their cardiac departments is further enhancing the demand for implantable devices. The integration of advanced diagnostic tools and patient management systems in hospitals is likely to improve patient outcomes and drive market growth in this channel.

Clinics:

Clinics, particularly specialized cardiac clinics, are increasingly becoming popular distribution channels for implantable cardiac monitors. These facilities typically focus on outpatient care and provide patients with personalized treatment plans, including monitoring solutions. The convenience of receiving care in a clinic setting, paired with the ability to access advanced monitoring technologies, is attracting patients seeking alternatives to hospital stays. The growth of telemedicine and remote monitoring services offered by clinics is further contributing to the expansion of this distribution channel. As patients seek to manage their cardiac health in a more accessible and efficient manner, the role of clinics in the implantable cardiac monitors market is expected to expand.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are becoming an increasingly important distribution channel for implantable cardiac monitors, primarily due to their focus on outpatient procedures. The ability to perform implantations in an ASC setting allows for cost-effective and efficient patient care. These facilities are equipped to handle shorter recovery times, encouraging more patients to opt for outpatient procedures. The growing trend of same-day discharge following minimally invasive cardiac procedures has made ASCs a viable alternative to traditional hospital settings. This shift is further supported by the increasing number of ASCs being developed globally, which is likely to enhance the availability of implantable cardiac monitors in the market.

Others:

This category includes various other distribution channels, such as home healthcare services and online platforms, that offer implantable cardiac monitors and related services. The rise of home healthcare has been driven by the growing preference for at-home patient management and the convenience it offers. As healthcare providers search for ways to improve access to cardiac monitoring solutions, the role of home healthcare services is expected to increase. Additionally, the availability of online platforms for purchasing medical devices is expanding, providing patients with more options for accessing implantable cardiac monitors. The evolving landscape of healthcare distribution channels is likely to stimulate growth within this segment.

By End User

Hospitals:

Hospitals serve as a critical end-user of implantable cardiac monitors, playing a vital role in the diagnosis and management of cardiac conditions. With advanced cardiac care technologies integrated into their infrastructure, hospitals are equipped to offer comprehensive monitoring and treatment options. The wide range of services offered, including surgical implantations and post-operative care, makes hospitals a preferred choice for patients. The increasing focus on improving patient outcomes and reducing hospital readmissions is driving hospitals to invest in advanced monitoring technologies, which further strengthens the demand for implantable devices in this setting. As hospitals continue to enhance their cardiac care capabilities, they are expected to remain a key end user in the market.

Cardiac Centers:

Cardiac centers are specialized facilities dedicated to diagnosing and treating heart-related conditions, making them significant end users of implantable cardiac monitors. These centers are staffed with cardiologists and skilled healthcare professionals who provide specialized care tailored to patients with complex cardiac issues. The growing trend of centralized cardiac care is driving more patients to seek treatment at these specialized facilities. Furthermore, the advanced technologies available at cardiac centers, including state-of-the-art monitoring devices, enhance the ability to deliver high-quality care. As awareness of the importance of specialized cardiac care continues to grow, the demand for implantable devices in cardiac centers is expected to rise.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are increasingly being recognized as significant end users of implantable cardiac monitors. These centers focus on outpatient procedures, providing a cost-effective alternative to hospital settings for device implantation. The ability to perform surgeries with shorter recovery times and same-day discharge options is attracting more patients seeking efficient care. ASCs offer the convenience of quick procedures and enhanced patient experiences, contributing to their growing role in the market. The continued development of ASCs as viable options for cardiac procedures is likely to increase their utilization of implantable devices, thereby driving market growth.

Others:

This category encompasses various other end users, including home healthcare providers and telemedicine platforms that cater to cardiac patients. As the demand for home healthcare solutions grows, these alternative end users are becoming increasingly important in the distribution and monitoring of implantable cardiac devices. The convenience and flexibility offered by home healthcare services allow patients to manage their cardiac health in a comfortable environment. Moreover, the advancement of telemedicine technologies facilitates remote monitoring and consultation, ensuring that patients continue to receive comprehensive care. As healthcare continues to evolve, the role of these alternative end users in the implantable cardiac monitors market is expected to grow.

By Region

The regional analysis of the implantable cardiac monitors market reveals significant variations in market dynamics across different geographic areas. North America is anticipated to dominate the market, accounting for approximately 40% of the total market share by 2035, driven by high healthcare expenditure and the presence of advanced healthcare infrastructure. The increasing prevalence of cardiovascular diseases in this region, coupled with the growing adoption of advanced cardiac monitoring technologies, is expected to fuel market growth. Additionally, favorable reimbursement policies and a strong focus on research and development in the region are likely to support the expansion of the market during the forecast period, with a CAGR of around 7.5% projected for North America.

Europe is another key region in the implantable cardiac monitors market, anticipated to hold a significant share, estimated at 30% by 2035. The region's growth is driven by the aging population and the increasing prevalence of heart-related diseases. Moreover, the growing awareness of the importance of cardiac monitoring and recent technological advancements in implantable devices are propelling market expansion. The Asia Pacific region is also witnessing rapid growth, projected to reach a market share of approximately 20% by 2035, fueled by rising healthcare investments and the expanding middle-class population. However, the Latin America and Middle East & Africa regions currently represent smaller shares of the market but are expected to experience growth opportunities as healthcare infrastructure improves and access to advanced medical technologies increases.

Opportunities

There are numerous opportunities for growth in the implantable cardiac monitors market, particularly as technological advancements continue to reshape the healthcare landscape. One of the primary opportunities lies in the development of next-generation monitoring devices that offer enhanced features such as wireless communication, advanced data analytics, and improved battery life. These innovations are likely to attract both healthcare providers and patients seeking more efficient and user-friendly cardiac monitoring solutions. Furthermore, the increasing trend towards personalized medicine presents a significant opportunity for manufacturers to develop tailored devices that cater to individual patient needs, thus improving treatment outcomes. As healthcare systems continue to evolve, the integration of artificial intelligence and machine learning into cardiac monitoring can provide valuable insights, driving the demand for advanced implantable devices.

Moreover, the growing emphasis on preventive healthcare and chronic disease management presents substantial opportunities within the implantable cardiac monitors market. As patients and healthcare providers prioritize proactive health management, the demand for continuous monitoring solutions is expected to rise. Additionally, the expansion of telehealth services and remote patient monitoring platforms can facilitate greater access to cardiac monitoring technologies, particularly in underserved regions. This can significantly improve patient outcomes while reducing the burden on healthcare systems. As countries globally invest in improving healthcare infrastructure and access to advanced technologies, the market for implantable cardiac monitors is poised for continued growth and innovation.

Threats

Despite the promising growth prospects for the implantable cardiac monitors market, several threats could pose challenges to its expansion. One of the significant threats includes stringent regulatory requirements that manufacturers must navigate to obtain approval for new devices. These regulations can prolong the time it takes for products to reach the market, consequently impacting sales and revenue growth. Furthermore, the high costs associated with the research and development of advanced implantable devices can deter smaller companies from entering the market, leading to reduced competition and innovation. Additionally, there is a growing concern regarding the cybersecurity vulnerabilities associated with connected medical devices, which could lead to data breaches and undermine patient trust in these technologies. Such threats necessitate heightened vigilance on the part of manufacturers to ensure compliance and security.

Another potential threat to the market is the increasing prevalence of alternative treatment options for cardiac conditions, such as non-invasive monitoring techniques and pharmacological advancements. As these alternatives gain traction, the demand for implantable cardiac monitors may be adversely affected. Additionally, economic factors such as fluctuations in healthcare funding and reimbursement policies can impact market growth. A downturn in economic conditions could lead to reduced healthcare spending, which may limit the adoption of advanced monitoring technologies. It is essential for industry stakeholders to remain vigilant about these potential threats and develop strategies to mitigate their effects to ensure sustainable growth in the implantable cardiac monitors market.

Competitor Outlook

• Abbott Laboratories
• Boston Scientific Corporation
• Medtronic Plc
• Biotronik SE & Co. KG
• Philips Healthcare
• St. Jude Medical, now part of Abbott
• iRhythm Technologies, Inc.
• Edwards Lifesciences Corporation
• LivaNova Plc
• Schiller AG
• SOMNOmedics GmbH
• Cardiac Insight, Inc.
• Dexcom, Inc.
• Hua Medicine
• Nipro Corporation

The competitive landscape of the implantable cardiac monitors market is characterized by the presence of several key players, each striving to gain a significant share through innovation and strategic partnerships. The industry is witnessing robust competition, with companies focusing on research and development to enhance the functionality and reliability of their products. Leading firms like Abbott Laboratories and Medtronic are investing heavily in advanced technology to develop next-generation cardiac monitors that integrate artificial intelligence and machine learning capabilities. This trend not only elevates patient outcomes but also enhances the efficacy of monitoring systems. Furthermore, strategic collaborations and mergers among key players are facilitating the sharing of expertise and resources, enabling companies to deliver comprehensive solutions tailored to the needs of healthcare providers and patients.

Abbott Laboratories is a prominent player in the implantable cardiac monitors market, known for its innovation and technological advancements. Its product portfolio includes the Insertable Cardiac Monitor (ICM), which offers long-term monitoring capabilities and features wireless data transmission for real-time analysis. This level of connectivity has positioned Abbott at the forefront of cardiac monitoring solutions. Similarly, Medtronic is recognized for its extensive range of cardiac devices, including Implantable Cardioverter Defibrillators (ICDs) and advanced monitoring systems. Medtronic’s commitment to improving patient care through continuous innovation has reinforced its market position, making it a leader in the industry.

Boston Scientific Corporation is another key player, focusing on developing innovative cardiac monitoring solutions that cater to the evolving needs of healthcare professionals and patients. The company's ICDs and Remote Monitoring System enhance patient management and ensure timely interventions. Furthermore, Biotronik SE & Co. KG stands out for its specialized monitoring devices, including the home-monitoring services that enhance patient compliance and health outcomes. As competition intensifies, companies are likely to explore new technologies and methodologies to differentiate their products, further enriching the diversity of solutions available in the implantable cardiac monitors market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Schiller AG
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Dexcom, Inc.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Hua Medicine
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 LivaNova Plc
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Medtronic Plc
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 SOMNOmedics GmbH
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Nipro Corporation
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Philips Healthcare
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Abbott Laboratories
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Biotronik SE & Co. KG
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Cardiac Insight, Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 iRhythm Technologies, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Boston Scientific Corporation
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Edwards Lifesciences Corporation
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 St. Jude Medical, now part of Abbott
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Implantable Cardiac Monitors Sales Market, By End User
    • 6.1.1 Hospitals
    • 6.1.2 Cardiac Centers
    • 6.1.3 Ambulatory Surgical Centers
    • 6.1.4 Others
  • 6.2 Implantable Cardiac Monitors Sales Market, By Application
    • 6.2.1 Arrhythmias
    • 6.2.2 Atrial Fibrillation
    • 6.2.3 Heart Failure
    • 6.2.4 Others
  • 6.3 Implantable Cardiac Monitors Sales Market, By Product Type
    • 6.3.1 Insertable Loop Recorders
    • 6.3.2 Implantable Cardioverter Defibrillators
    • 6.3.3 Subcutaneous Implantable Cardioverter Defibrillators
    • 6.3.4 Cardiac Resynchronization Therapy Devices
    • 6.3.5 Others
  • 6.4 Implantable Cardiac Monitors Sales Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Clinics
    • 6.4.3 Ambulatory Surgical Centers
    • 6.4.4 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Implantable Cardiac Monitors Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Implantable Cardiac Monitors Sales market is categorized based on

By Product Type

• Insertable Loop Recorders
• Implantable Cardioverter Defibrillators
• Subcutaneous Implantable Cardioverter Defibrillators
• Cardiac Resynchronization Therapy Devices
• Others

By Application

• Arrhythmias
• Atrial Fibrillation
• Heart Failure
• Others

By Distribution Channel

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Others

By End User

• Hospitals
• Cardiac Centers
• Ambulatory Surgical Centers
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Abbott Laboratories
• Boston Scientific Corporation
• Medtronic Plc
• Biotronik SE & Co. KG
• Philips Healthcare
• St. Jude Medical, now part of Abbott
• iRhythm Technologies, Inc.
• Edwards Lifesciences Corporation
• LivaNova Plc
• Schiller AG
• SOMNOmedics GmbH
• Cardiac Insight, Inc.
• Dexcom, Inc.
• Hua Medicine
• Nipro Corporation